BCL2 antibody
Product Specifications
Background
Suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. Regulates cell death by controlling the mitochondrial membrane permeability. Appears to function in a feedback loop system with caspases. Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor(APAF-1). May attenuate inflammation by impairing NLRP1-inflammasome activation, hence CASP1 activation and IL1B release(PubMed:17418785).
Synonyms
Apoptosis regulator Bcl-2|BCL2
Gene ID
596
UniProt
P10415
Host
Mouse
Reactivity
Human
Immunogen
B-cell CLL/lymphoma 2
Target
BCL2
Clonality
Monoclonal
Isotype
IgG2a
Clone
8A10
Applications
ELISA, WB, IP, IHC
Field of Research
Neuroscience, Cancer, Immunology, Cardiovascular
Purification
Protein A+G purification
Dilution
WB: 1:1000-1:10000; IP: 1:500-1:5000; IHC: 1:100-1:2000
Purity
≥95% as determined by SDS-PAGE
Form
Liquid
Molecular Weight
26 kDa
Storage Conditions
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20°C for 12 months(Avoid repeated freeze / thaw cycles.)
CAS Number
9007-83-4
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6317866-01 0.1 mL
LZTS2, CT (LZTS2, KIAA1813, LAPSER1, Leucine zipper putative tumor suppressor 2, Protein LAPSER1) (MaxLight 750)
Ask
View Details 
MBS6317866-02 5x 0.1 mL
LZTS2, CT (LZTS2, KIAA1813, LAPSER1, Leucine zipper putative tumor suppressor 2, Protein LAPSER1) (MaxLight 750)
Ask
View Details 
ARP35703_T100-FITC 100 µL
FUBP1 Antibody - N-terminal region: FITC (ARP35703_T100-FITC)
Ask
View Details